Increased Antibiotic Resistance in Children with Helicobacter pylori Infection: A Retrospective Study

Luca Helmbold1, Beniam Ghebremedhin2, Aliyah Bellm3

  • 1Center for Child and Adolescent Medicine, Center for Clinical and Translational Research (CCTR), Helios University Hospital Wuppertal, Witten/Herdecke University, 42283 Wuppertal, Germany.

Insights

Children with recurrent abdominal pain may have Helicobacter pylori (HP) infection. High rates of antibiotic resistance to amoxicillin, clarithromycin, and metronidazole were found, potentially impacting treatment success.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Microbiology

Background:

  • Recurrent abdominal pain in children can indicate Helicobacter pylori (HP) infection.
  • Diagnosis typically involves esophagogastroduodenoscopy (EGD) with histological and microbiological analysis.
  • Understanding antibiotic resistance patterns is crucial for effective treatment.

Purpose of the Study:

  • To analyze HP positive cultures and antibiograms in pediatric patients.
  • To correlate microbiological findings with clinical and histopathological data.
  • To assess antibiotic resistance prevalence in HP isolates from children.

Main Methods:

  • Retrospective analysis of data from 124 children undergoing EGD.
  • Collection and analysis of HP cultures and antibiograms.
  • Evaluation of clinical symptoms and histopathological findings.

Main Results:

  • HP gastritis diagnosed in 54% of patients.
  • High prevalence of antibiotic resistance: 40% resistant to at least one antibiotic.
  • Specific resistances noted: amoxicillin (20%), clarithromycin (45%), metronidazole (59%).
  • 16% of isolates showed resistance to two or more antibiotics.

Conclusions:

  • Remarkably high antibiotic resistance rates to amoxicillin, metronidazole, and clarithromycin in the study cohort.
  • Increased multi-antibiotic resistance in HP-infected children.
  • Antibiotic resistance may negatively impact HP eradication therapy outcomes.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
601
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
220
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
286
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
637
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
318
Antibiotic Selection00:57

Antibiotic Selection

Overview
55.9K